ArticleCardiology and therapy2026

Cardiac Safety Outcomes in Delandistrogene Moxeparvovec Clinical Trials for Duchenne Muscular Dystrophy with Up to 5 Years of Follow-up.

Aravindhan Veerapandiyan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.